MOREAU, Benoît,BILODEAU, Mark T.,WHALEN, Kerry,MEETZE, Kristan,SINGH, Sukhjeet,WOOSTER, Richard,LEMELIN, Charles-Andre
申请号：
AU2018236864
公开号：
AU2018236864A1
申请日:
2018.09.28
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2018236864A120181018.pdf#####Abstract The present teachings relate to compounds and compositions for treatment of cancers. In some embodiments, the 5 composition comprises a platinum (IV) complex having at least one reacting group for reacting with a functional group on a protein, engineered protein, antibody, antibody fragment, peptide, agonist, antagonist, aptamer or ligand which may be capable of recognizing a selected target call 10 population, and/or derivatives/analogs/mimics thereof. W: NRPortbl GHMatters MICHELES 10670247_1.docx 19/09/184/31 Eff icacy of Piatinums in A278O Xenografts 3500 V cIf t D "MR C2SSC1a0r 2000 o ~00 gx" F. 500 5 t~D00s .. ....... ........ ........ ....... ........ ........ ........ ....... ........ ........ ....... ........ ......$. ......
